Northwestern Medicine scientists have developed a new prognostic tool for clinicians treating patients with large B-cell lymphoma. The predictive scale enhances the widely used International Prognostic Index.
Published in the Journal of Neuroscience, a discovery by Marco Martina, MD, PhD, associate professor in Physiology, sheds new light on the selective vulnerability of cell types in preclinical models of ataxia.
Variations in DNA sequence may have a significant impact on how humans respond to dengue virus. A group of scientists from Nicaragua, the University of California-Berkeley and Feinberg will seek to uncover genetic variants that make certain people more susceptible to life-threatening forms of the infection.
Second-year medical student Chaitanya Medicherla explores the effects of immune cells on cancer development as part of his Area of Scholarly Concentration research project.
Jennifer Heller, a fifth-year PhD candidate, uses animal models of colitis to better understand how the adaptive immune system becomes dysregulated.
The finding may be useful in shortening drug treatments for those with the disease.
Serdar Bulun, MD, authored an article in the New England Journal of Medicine that combines recent uterine fibroid research into a useful framework for scientists, clinicians, patients and the pharmaceutical industry.
Scientists are working to determine if a specific receptor inhibitor could be used to augment chemotherapy or prevent relapse in individuals with the disease.
While it’s long been known that oxytocin promotes feelings of love, social bonding, and wellbeing, only recently have scientists discovered it’s link to anxiety-producing bad memories.
In the first step toward animal-to-human transplants of insulin-producing cells for people with type 1 diabetes, Northwestern Medicine® scientists have successfully transplanted islets, the cells that produce insulin, from one species to another. And the islets survived without immunosuppressive drugs.
Notifications